Holen Sie sich die Stockscreener-App
488.27
0.38%
-1.86
Vorhandelsmarkt:
484.47
-3.80
-0.78%
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Warum fällt ISRG?
Forum
Prognose
Aktiensplit
Schlusskurs vom Vortag:
$490.13
Offen:
$487.46
24-Stunden-Volumen:
1.71M
Relative Volume:
0.78
Marktkapitalisierung:
$174.93B
Einnahmen:
$8.35B
Nettoeinkommen (Verlust:
$2.32B
KGV:
76.17
EPS:
6.41
Netto-Cashflow:
$1.30B
1W Leistung:
+6.70%
1M Leistung:
+0.79%
6M Leistung:
+2.05%
1J Leistung:
+29.39%
1-Tages-Spanne:
$483.69
$494.64
1-Wochen-Bereich:
$442.90
$529.19
52-Wochen-Spanne:
$364.17
$616.00
Intuitive Surgical Inc Stock (ISRG) Company Profile
Firmenname
Intuitive Surgical Inc
Sektor
Telefon
(408) 523-2100
Adresse
1020 KIFER ROAD, SUNNYVALE
Vergleichen Sie ISRG mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
ISRG
Intuitive Surgical Inc
|
488.27 | 174.93B | 8.35B | 2.32B | 1.30B | 6.41 |
|
BDX
Becton Dickinson Co
|
202.04 | 58.01B | 20.64B | 1.73B | 2.94B | 6.02 |
|
ALC
Alcon Inc
|
91.42 | 45.22B | 9.91B | 1.02B | 665.00M | 2.05 |
|
RMD
Resmed Inc
|
213.97 | 31.43B | 4.93B | 1.25B | 1.38B | 8.47 |
|
COO
The Cooper Companies, Inc.
|
77.80 | 15.49B | 3.90B | 392.30M | 288.10M | 1.95 |
Intuitive Surgical Inc Stock (ISRG) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2024-12-02 | Hochstufung | Morgan Stanley | Equal-Weight → Overweight |
| 2024-08-02 | Hochstufung | Redburn Atlantic | Neutral → Buy |
| 2024-07-10 | Bestätigt | Citigroup | Buy |
| 2024-05-30 | Eingeleitet | Goldman | Buy |
| 2023-11-17 | Eingeleitet | HSBC Securities | Buy |
| 2023-07-19 | Eingeleitet | Robert W. Baird | Outperform |
| 2023-04-19 | Bestätigt | BTIG Research | Buy |
| 2023-04-19 | Bestätigt | BofA Securities | Buy |
| 2023-04-19 | Bestätigt | Citigroup | Buy |
| 2023-04-19 | Bestätigt | Evercore ISI | In-line |
| 2023-04-19 | Bestätigt | JP Morgan | Overweight |
| 2023-04-19 | Bestätigt | Morgan Stanley | Equal-Weight |
| 2023-04-19 | Bestätigt | RBC Capital Mkts | Outperform |
| 2023-04-19 | Bestätigt | Raymond James | Outperform |
| 2023-04-19 | Bestätigt | Stifel | Buy |
| 2023-04-19 | Bestätigt | Truist | Buy |
| 2023-04-19 | Bestätigt | Wells Fargo | Overweight |
| 2023-03-29 | Eingeleitet | UBS | Neutral |
| 2023-03-23 | Eingeleitet | William Blair | Outperform |
| 2022-10-18 | Eingeleitet | Barclays | Overweight |
| 2022-10-13 | Eingeleitet | Mizuho | Neutral |
| 2022-10-12 | Eingeleitet | Jefferies | Hold |
| 2022-04-13 | Eingeleitet | Truist | Buy |
| 2022-04-06 | Eingeleitet | Wolfe Research | Peer Perform |
| 2022-03-25 | Eingeleitet | RBC Capital Mkts | Outperform |
| 2022-03-02 | Fortgesetzt | BofA Securities | Buy |
| 2022-02-02 | Hochstufung | UBS | Neutral → Buy |
| 2022-01-31 | Hochstufung | Piper Sandler | Neutral → Overweight |
| 2022-01-25 | Herabstufung | Redburn | Buy → Neutral |
| 2022-01-21 | Bestätigt | BTIG Research | Buy |
| 2022-01-21 | Hochstufung | Citigroup | Neutral → Buy |
| 2022-01-21 | Bestätigt | Deutsche Bank | Hold |
| 2022-01-21 | Bestätigt | Evercore ISI | In-line |
| 2022-01-21 | Bestätigt | Morgan Stanley | Equal-Weight |
| 2022-01-21 | Bestätigt | Piper Sandler | Neutral |
| 2022-01-21 | Bestätigt | Raymond James | Outperform |
| 2022-01-21 | Bestätigt | Robert W. Baird | Outperform |
| 2022-01-21 | Bestätigt | Stifel | Buy |
| 2022-01-21 | Bestätigt | UBS | Neutral |
| 2022-01-21 | Bestätigt | Wells Fargo | Overweight |
| 2022-01-10 | Hochstufung | BTIG Research | Neutral → Buy |
| 2021-10-01 | Herabstufung | Citigroup | Buy → Neutral |
| 2021-07-21 | Bestätigt | BofA Securities | Neutral |
| 2021-07-21 | Bestätigt | Citigroup | Buy |
| 2021-07-21 | Bestätigt | JP Morgan | Overweight |
| 2021-07-21 | Bestätigt | Morgan Stanley | Equal-Weight |
| 2021-07-21 | Bestätigt | Piper Sandler | Neutral |
| 2021-07-21 | Bestätigt | SVB Leerink | Mkt Perform |
| 2021-07-21 | Bestätigt | Stifel | Buy |
| 2021-07-21 | Bestätigt | UBS | Neutral |
| 2021-07-21 | Bestätigt | Wells Fargo | Overweight |
| 2021-07-14 | Bestätigt | Goldman | Buy |
| 2021-06-01 | Hochstufung | Evercore ISI | Underperform → In-line |
| 2021-04-21 | Hochstufung | Oppenheimer | Underperform → Perform |
| 2021-04-21 | Hochstufung | Robert W. Baird | Neutral → Outperform |
| 2021-04-01 | Eingeleitet | Citigroup | Buy |
| 2020-12-15 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
| 2020-09-28 | Eingeleitet | Argus | Buy |
| 2020-09-11 | Eingeleitet | Wolfe Research | Outperform |
| 2020-09-08 | Herabstufung | BofA Securities | Buy → Neutral |
| 2020-09-02 | Eingeleitet | Robert W. Baird | Neutral |
| 2020-07-20 | Bestätigt | Bernstein | Outperform |
| 2020-04-28 | Herabstufung | Piper Sandler | Overweight → Neutral |
| 2020-04-17 | Herabstufung | CFRA | Hold → Sell |
| 2020-04-17 | Herabstufung | SVB Leerink | Outperform → Mkt Perform |
| 2020-04-09 | Herabstufung | Evercore ISI | In-line → Underperform |
| 2020-04-01 | Herabstufung | Oppenheimer | Perform → Underperform |
| 2020-01-27 | Herabstufung | Deutsche Bank | Buy → Hold |
| 2019-12-12 | Bestätigt | Wells Fargo | Outperform |
| 2019-11-21 | Eingeleitet | Oppenheimer | Perform |
| 2019-07-19 | Bestätigt | Canaccord Genuity | Buy |
| 2019-04-22 | Bestätigt | Canaccord Genuity | Buy |
| 2019-04-02 | Eingeleitet | Deutsche Bank | Buy |
| 2018-10-31 | Bestätigt | Piper Jaffray | Overweight |
| 2018-10-19 | Hochstufung | Canaccord Genuity | Hold → Buy |
Alle ansehen
Intuitive Surgical Inc Aktie (ISRG) Neueste Nachrichten
Surgical Robots Market poised for steady growth driven by rising adoption in minimally invasive procedures - openPR.com
J&J reports completion of first cases with Ottava robotic system - BioWorld MedTech
Intuitive Surgical, Inc. (ISRG) Reports Next Week: Wall Street Expects Earnings Growth - Yahoo Finance
RBC Capital Adjusts Intuitive Surgical (ISRG) Price Target Ahead of Q1 Results | ISRG Stock News - GuruFocus
Can ISRG Stock Revive its Growth Momentum After the Sudden Slide? - Nasdaq
RBC Cuts Price Target on Intuitive Surgical to $630 From $670, Keeps Outperform Rating - MarketScreener
J&J completes first surgeries with Ottava robot - Yahoo Finance
Intuitive Surgical, Inc. (ISRG) Stock Falls Amid Market Uptick: What Investors Need to Know - MSN
Minimally Invasive Surgical Devices Patent Landscape Report 2025, with Intuitive Surgical, LSI Solutions, Tendyne Holdings, Ethicon Endo Surgery and Invuity - Ortho Spine News
Tariffs top of mind for medtech firms this earnings season - MedTech Dive
Intuitive Surgical (ISRG) Price Target Lowered Ahead of Q1 Resul - GuruFocus
Intuitive Surgical Shares May Rise as FDA Clears SureForm 45 Stapler - Yahoo Finance
Intuitive Surgical price target lowered to $560 from $622 at BTIG - TipRanks
Intuitive’s SureForm 45 stapler receives US FDA clearance for use in thoracic, colorectal and urologic procedures - Pharmabiz.com
Intuitive Surgical (ISRG) Sees Robust Growth with Da Vinci Syste - GuruFocus
Nasdaq Market Whiplash: 3 Stocks to Buy Hand Over Fist and Hold for Decades - The Motley Fool
Intuitive Surgical Gets Rating Upgrade. It's No. 1 In Its Industry; Profits, Sales Climbing. - MSN
Why Intuitive Surgical (ISRG) Is Among the Best Medical Stocks to Buy According to Billionaires - Insider Monkey
Intuitive wins FDA clearance for single-port robotic surgery stapler - MedTech Dive
Intuitive Obtains FDA Nod for Single-Port Stapler - Medical Device and Diagnostic industry
Intuitive Surgical Inc (ISRG) Shares Gap Down to $482.935 on Apr 10 - GuruFocus
Intuitive Surgical: Premium Valuation Meets Mounting Headwinds (Downgrade) (NASDAQ:ISRG) - Seeking Alpha
Intuitive (ISRG) Gains FDA Approval for New SP SureForm 45 Stapl - GuruFocus
10 Best Medical Stocks to Buy According to Billionaires - Insider Monkey
SoftBank Bets $200M On CMR Surgical, The UK Startup Taking On $178B Intuitive With Robots That Have Performed 30,000 Surgeries - Yahoo Finance
May 30th Options Now Available For Intuitive Surgical (ISRG) - Nasdaq
Intuitive snags FDA clearance for its single-port surgical stapler - Fierce Biotech
Intuitive Surgical (NasdaqGS:ISRG) Gains FDA Clearance for Innovative SP SureForm 45 Stapler - simplywall.st
FDA clears first stapler for single-port robotics from Intuitive - MassDevice
Intuitive Surgical, Inc. Announces U.S. FDA Clears First Stapler Designed for Single-port Robotic Surgery - MarketScreener
Intuitive Surgical (ISRG) Moves 14.3% Higher: Will This Strength Last? - Yahoo Finance
FDA clears Intuitive’s new stapler for specific surgeries By Investing.com - Investing.com India
Intuitive Surgical Obtains Clearance for Robotic Surgery Stapler From US FDA - MarketScreener
Intuitive Wins FDA Nod for 1st Stapler Designed for Single-Port Robotic Surgery - Medical Product Outsourcing
FDA clears Intuitive's new stapler for specific surgeries - Investing.com
U.S. FDA clears first stapler designed for single-port robotic surgery - GlobeNewswire
Intuitive Surgical receives FDA clearance for SP SureForm 45 stapler - TipRanks
Surgical Innovation Breakthrough: Intuitive Launches First-Ever Single-Port Robotic Stapler - Stock Titan
Stocks Showing Improving Market Leadership: Intuitive Surgical Earns 89 RS Rating - Investor's Business Daily
Surgical Robotics System Market: Navigating the Future of Precision Healthcare - openPR.com
Intuitive Surgical, Inc. (ISRG) Stock Moves -1.29%: What You Should Know - MSN
Intuitive Surgical Joins Rank Of Stocks With 95-Plus Composite Rating - Investor's Business Daily
Healthcare Stocks Drop Further -- Healthcare Roundup - MarketScreener
A Closer Look at Intuitive Surgical's Options Market Dynamics - Benzinga
Trump Tariffs Will Sow Long-term Structural Dislocation, Oppenheimer Says - MarketScreener
What to Expect From Intuitive Surgical’s Q1 2025 Earnings Report - Nasdaq
Citigroup Adjusts Intuitive Surgical Price Target to $640 From $711, Maintains Buy Rating - MarketScreener
Intuitive Surgical, Inc. (ISRG) is Attracting Investor Attention: Here is What You Should Know - MSN
What To Expect From Intuitive Surgical’s Q1 2025 Earnings Report - Barchart.com
The surgical robots making waves in endometriosis care - Hospital Healthcare Europe
Down 18%, Should You Buy the Dip on Intuitive Surgical Stock? - MSN
Finanzdaten der Intuitive Surgical Inc-Aktie (ISRG)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.78%
0.93%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):